Scripintelligence - Cochrane group: Roche's refusal of access to Tamiflu data leaves questions unanswered

Scrip Clinica Scrip Regulatory Affairs Scrip Clinical Research AnimalPharm

Advanced Search

Research & Development

Cochrane group: Roche's refusal of access to Tamiflu data leaves questions unanswered
18 January 2012
Pial Ganguli

Please Login to read the full article.

Not a subscriber? Subscribe to Scrip Request a FREE Trial

RELATED CONTENT

NEWS Scrip News

US Capitol Capsule: Health reform draws amicus attention, but most Americans 'meh' on impact
Clinical trial reporting still dangerously inadequate, says BMJ
US Capitol Capsule: Use of mind-altering medicines in children, elderly under fire
US Capitol Capsule: IOM focus on affordable 'essential' benefits expected to stir debate on drug prices

Other Informa News

ANALYSIS Scrip Analysis

What have been major findings/breakthroughs in the anti-infectives area in the last decade?

Other Informa Analysis

COMMENT Scrip Comment

EU paediatric studies: can fines succeed where carrots and sticks have not?

Other Informa Comment

Keep on the telehealth path – industry shows way to go

FEATURES Scrip Features

Other Informa Features

EVENTS

Understanding the basics of EU regulatory affairs

Today

The Rembrandt Hotel, London

Clinical trial regulatory and guideline requirements

07 June 2012

The Rembrandt Hotel, London

2012 BIO International Convention

18 June 2012

Boston Convention & Exhibition Center, Boston, MA

JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36

Home

Therapy Sector

Generics

Business

Policy & Regulation

Research & Development

International

Terms & Conditions

Scrip Regulatory Affairs

Scrip Clinical Research

Animal Pharm